黄芩苷类脂纳米囊制剂的制备及大鼠口服药物动力学
Preparation and pharmacokinetics of baicalin lipid nanocapsules

DOI: 10.6040/j.issn.1671-7554.0.2015.303

Keywords: 黄芩苷,类脂纳米囊,单纯形网格法,相转化法,
Baicalin,Phase inversion-based method,Simplex lattice,Lipid nanocapsules

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Lu CM, Lin LC, Tsai TH. Determination and pharmacokinetic study of gentiopicroside, geniposide, baicalin, and swertiamarin in chinese herbal formulae after oral administration in rats by LC-MS/MS[J]. Molecules, 2014, 19(12): 21560-21578.
[2]	靳世英,袁海龙,靳士晓,等.黄芩苷纳米晶体微丸的制备及其药代动力学初步研究[J].中国中药杂志, 2013, 38(8): 1156-1159. JIN Shiying, YUAN Hailong, JIN Shixiao, et al. Preparation of baicalin nanocrystal pellets and preliminary study on its pharmacokinetics[J]. 2013, 38(8): 1156-1159.
[3]	Heurtault B, Saulnier P, Pech B, et al. A novel phase inversion-based process for the preparation of lipid nanocarriers[J]. Pharm Res, 2002, 19(6): 875-880.
[4]	Andrae-Marobela K, Ghislain FW, Okatch H, et al. Polyphenols: a diverse class of multi-target anti-HIV-1 agents[J]. Curr Drug Metab, 2013, 14(4): 392-413.
[5]	Parejiya PB, Patel RC, Mehta DM, et al. Quick dissolving films of nebivolol hydrochloride: formulation and optimization by a simplex lattice design[J]. J Clin Invest, 2013, 43(4): 343-351.
[6]	何琳,丁沐淦,卢秀霞,等. 黄芩苷在不同 pH 值缓冲液中理化常数的测定[J]. 西北药学杂志, 2012, 27(3): 208-211. HE Lin, DING Mugan, LU Xiuxia, et al. Physicochemical properties of baicalin in different pH phosphate buffer solutions[J]. Northwest Pharmaceutical Journal, 2012, 27(3): 208-211.
[7]	He MY, Deng YX, Shi QZ, et al. Comparative pharmacokinetic investigation on baicalin and wogonoside in type 2 diabetic and normal rats after oral administration of traditional chinese medicine Huanglian Jiedu decoction[J]. J Ethnopharmacol, 2014, 155(1): 334-342.
[8]	Lee B, Sur B, Shim I, et al. Baicalin improves chronic corticosterone-induced learning and memory deficits via the enhancement of impaired hippocampal brain-derived neurotrophic factor and cAMP response element-binding protein expression in the rat[J]. J Nat Med, 2014, 68(1): 132-143.
[9]	Liu XB, Gu JM, Fan YQ, et al. Baicalin attenuates acute myocardial infarction of rats via mediating the mitogen-activated protein kinase pathway[J]. Biol Pharm Bull, 2013, 36(6): 988-994.
[10]	Xu MJ, Chen XM, Gu Y, et al. Baicalin can scavenge peroxynitrite and ameliorate endogenous peroxynitrite-mediated neurotoxicity in cerebral ischemia-reperfusion injury[J]. J Ethnopharmacol, 2013, 150(1): 116-124.
[11]	Desai PP, Date AA, Patravale VB. Overcoming poor oral bioavailability using nanoparticle formulations-opportunities and limitations[J]. Drug Discov Today Technol, 2012, 9(2): e87-e95.
[12]	Perrier T, Saulnier P, Fouchet F, et al. Post-insertion into lipid nanocapsules(LNCs): from experimental aspects to mechanisms[J]. Int J Pharm, 2010, 396(1-2): 204-209.
[13]	Wu HY, Long XY, Yuan F, et al. Combined use of phospholipid complexes and self-emulsifying microemulsions for improving the oral absorption of a BCS class IV compound, baicalin[J]. Acta Pharm Sinica, 2014, 4(3): 217-226.
[14]	Lu T, Song J, Huang F, et al. Comparative pharmacokinetics of baicalin after oral administration of pure baicalin, radix scutellariae extract and huang-lian-jie-du-tang to rats[J]. J Ethnopharmacol, 2007, 110(3): 412-418.
[15]	Sakurama H, Kishino S, Uchibori Y, et al. β-Glucuronidase from Lactobacillus brevis useful for baicalin hydrolysis belongs to glycoside hydrolase family 30[J]. Appl Microbiol Biotechnol, 2014, 98(9): 4021-4032.
[16]	Farris P, Yatskayer M, Chen N, et al. Evaluation of efficacy and tolerance of a nighttime topical antioxidant containing resveratrol, baicalin, and vitamin E for treatment of mild to moderately photodamaged skin[J]. J Drugs Dermatol, 2014, 13(12): 1467-1472.
[17]	Zhao L, Wei Y, Huang Y, et al. Nanoemulsion improves the oral bioavailability of baicalin in rats: in vitro and in vivo evaluation[J]. Int J Nanomedicine, 2013, 8: 3769-3779.
[18]	王超,翟光喜.芹黄素类脂纳米囊的制备与理化性质考察[J].食品与药品, 2012, 14(1): 21-25. WANG Chao, ZHAI Guangxi. Preparation and characterization of apigenin-loaded lipid nanocapsules[J]. Food and Drug, 2012, 14(1): 21-25.
[19]	Binkhathlan Z, Lavasanifar A. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives[J]. Curr Cancer Drug Targets, 2013, 13(3): 326-346.
[20]	Zhai YJ, Liu MR, Wan M, et al. Preparation and characterization of puerarin-Loaded lipid nanocapsules[J]. J Nanosci Nanotechno, 2015, 15(4): 2643-2649.

Full-Text